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ABSTRACT 
Chronic infection with hepatitis B virus (HBV) affects 240 million people worldwide and may cause 
liver disease including hepatocellular carcinoma (HCC). Initially patients have high levels of HBV 
DNA in their blood, no liver disease and express the e antigen (HBeAg). At some point an immune 
response is mounted and the viral load decreases with several log10 copies/ml, they lose HBeAg and 
severe liver damage may follow if the virus is not cleared efficiently. Meanwhile, the circulating levels 
of the surface antigen (HBsAg), not bound to viral particles, remain high. In the liver, the viral DNA 
might integrate in the genome of hepatocytes. This has been proposed as a mechanism potentially 
promoting cancer development. 
The aims of this thesis were to investigate the mechanisms behind the great decline in HBV DNA at 
loss of HBeAg while the HBsAg levels remain relatively stable, to evaluate the utility of 
quantification of HBsAg in serum as a marker for liver damage, and to assess the extent of integrated 
HBV DNA in liver biopsies. 
The main methods used in this thesis are various types of polymerase chain reaction (PCR). The 
material was blood samples and liver biopsies from chronic carriers of HBV. Viral load in the liver, 
both DNA and RNA, was quantified by real-time PCR and integrated HBV DNA sequences were 
identified using Alu-PCR. 
Serum levels of HBV DNA and HBsAg correlated with intrahepatic levels of covalently closed 
circular DNA (cccDNA), the template for new viral particles and antigens. By comparing viral load 
between patients positive or negative for HBeAg it was found that the 3-5 log10 decline of HBV DNA 
at HBeAg seroconversion mainly is explained by decrease in cccDNA and reduced transcriptional 
efficiency of pregenomic RNA (pgRNA), the template for virus DNA. However, retention of viral 
particles and decreased half-life of virions seem to have an additional impact. 
By comparing results of serum levels of HBsAg and histological examination of liver biopsies it was 
concluded that a cut-off of <3.0 log10 IU/ml of HBsAg and <4.0 log10 copies/ml could identify patients 
with low liver damage with a specificity of 96%. 
With Alu-PCR integrated sequences were detected in 36 of 48 liver biopsies examined. In total 45 
integrated sequences were analysed from 32 different patients. Integration of HBV DNA was thus a 
very common event in the chronic HBV carriers. 
In summary, this study contributes to the understanding of the replication and integration of the 
hepatitis B virus. 
 
Keywords: hepatitis B virus, HBV DNA, HBsAg, replication, integration 
 
ISBN: 978-91-628-8986-9 
http://hdl.handle.net/2077/34851 
